Equities

Cabio Biotech Wuhan Co Ltd

688089:SHH

Cabio Biotech Wuhan Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)14.18
  • Today's Change-0.04 / -0.28%
  • Shares traded2.06m
  • 1 Year change-35.43%
  • Beta1.3962
Data delayed at least 15 minutes, as of Jul 26 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cabio Biotech Wuhan Co Ltd is a China-based company principally engaged in biotechnology business. The Company is mainly engaged in the research and development, production and sales of polyunsaturated fatty acids arachidonic acid (ARA), algal oil docosahexaenoic acid (DHA) and sialic acid (SA), and natural beta-carotene products. Its products are mainly used in infant formula food, dietary supplements, nutritional health food and formula food for special medical purposes. The Company integrates industrial strain-oriented optimization technology, fermentation fine control technology, and efficient separation, purification and preparation technology, and provides nutrient products and innovative solutions for customers in the global nutrition and health field through sustainable microbial synthesis and manufacturing methods. The Company mainly conducts its business in domestic and overseas markets.

  • Revenue in CNY (TTM)473.06m
  • Net income in CNY101.38m
  • Incorporated2004
  • Employees508.00
  • Location
    Cabio Biotech Wuhan Co LtdWuhan Medical Industry ParkJiangxia Avenue, Jiangxia DistrictWUHAN 430075ChinaCHN
  • Phone+86 2 767845289
  • Fax+86 2 765520985
  • Websitehttp://www.cabio.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Qingdao Richen Food Co Ltd371.24m58.68m2.22bn405.0037.783.10--5.970.5950.5953.767.240.39096.456.48916,651.606.189.627.9211.4537.4843.3815.8122.841.27--0.195744.4116.498.6410.52-4.1767.72--
Baotou Huazi Industry Co Ltd628.88m-23.88m2.32bn505.00--1.46--3.69-0.0492-0.04921.303.270.31483.7513.721,245,298.00-1.20-2.49-1.38-2.625.979.13-3.80-19.840.7866-0.18150.1014--72.9757.67111.43------
Xinjiang Tianrun Dairy Co Ltd2.72bn91.59m2.34bn3.51k25.210.9638--0.86070.29040.29048.637.600.56423.9019.78776,973.201.735.052.587.5917.7919.553.077.500.47729.750.385530.1212.6213.17-27.744.4620.87-1.44
Cabio Biotech Wuhan Co Ltd473.06m101.38m2.39bn508.0023.721.59--5.050.59770.59772.798.920.29482.492.27931,222.906.017.816.558.3441.3446.9620.4028.656.19--0.00839.862.399.1841.95-1.1989.01--
YouYou Foods Co Ltd1.01bn111.99m2.42bn1.19k21.651.29--2.400.26140.26142.354.390.49712.52311.62847,145.205.529.585.8110.3727.7332.4111.1116.8413.46--0.006480.50-5.68-2.58-24.38-8.20-17.69--
Apple Flavor & Fragrance Group Co Ltd2.80bn85.93m2.51bn1.14k28.870.7753--0.89510.22690.22697.398.450.73653.946.432,459,969.002.865.213.396.3614.3016.083.885.845.99--0.033929.88-13.092.17-17.50-3.8013.86-1.89
Suzhou Weizhixiang Food Co Ltd762.89m118.69m2.56bn508.0021.542.01--3.350.86040.86045.539.200.567118.7588.831,501,762.008.8215.349.3816.4525.6225.9115.5617.659.44--0.042344.340.103811.39-5.4213.7486.15--
Data as of Jul 26 2024. Currency figures normalised to Cabio Biotech Wuhan Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

6.64%Per cent of shares held by top holders
HolderShares% Held
First Seafront Fund Management Co., Ltd.as of 31 Dec 20232.90m1.72%
Huashang Fund Management Co., Ltd.as of 31 Dec 20232.70m1.60%
UBS Asset Management Switzerland AGas of 24 Nov 20221.47m0.87%
China Asset Management Co., Ltd.as of 31 Dec 20231.24m0.74%
Shenwan Hongyuan Securities Co., Ltd. (Invt Mgmt)as of 24 Nov 2022840.00k0.50%
Great Wall Fund Management Co., Ltd.as of 31 Dec 2023551.05k0.33%
Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023444.09k0.26%
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023393.14k0.23%
Taikang Asset Management Co. Ltd.as of 24 Nov 2022350.00k0.21%
Harvest Fund Management Co., Ltd.as of 31 Dec 2023290.10k0.17%
More ▼
Data from 31 Dec 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.